Search results
Results from the WOW.Com Content Network
The Philippines is considering re-introducing a dengue vaccine whose use it halted because of links to the deaths of several children, as authorities battle to contain a dengue outbreak that has ...
The Dengvaxia controversy (locally [dɛŋˈvakʃa]) occurred in the Philippines when the dengue vaccine Dengvaxia was found to increase the risk of disease severity for some people who had received it. [1] [2] A vaccination program run by the Philippine Department of Health (DOH) administered Sanofi Pasteur's Dengvaxia to schoolchildren. [3]
Dengue vaccine is a vaccine used to prevent dengue fever in humans. [9] Development of dengue vaccines began in the 1920s but was hindered by the need to create immunity against all four dengue serotypes. [10] As of 2023, there are two commercially available vaccines, sold under the brand names Dengvaxia and Qdenga. [11] [12]
The World Health Organization has prequalified a new dengue vaccine recommended for use in children in areas where mosquito transmission to humans is high.
Last week WHO reported there were 6.7 million suspected cases of dengue in the Americas, an increase of 206% compared with the same period in 2023. In March, authorities in Rio de Janeiro declared a public health emergency over its dengue epidemic and the country began rolling out the Takeda vaccine, aiming to inoculate at least 3 million ...
In order to slow the spread of the disease and work to achieve herd immunity, Brazil preemptively purchased the entire global stock of Qdenga dengue two-dose vaccine made by the Japanese pharmaceutical company Takeda in January 2024. However, only six million doses were planned to be created for 2024, which would only be enough to vaccinate 1.5 ...
The US Centers for Disease Control and Prevention issued a warning to doctors on Tuesday to be on the look out for cases of dengue. A surge in dengue cases globally is raising the risk that people ...
South America is seeing a surge in cases of the mosquito-borne disease dengue during the southern hemisphere summer, prompting Brazil to roll out a novel vaccine campaign, while in Argentina many ...